# Examining Effects of Intrarosa in Women With Genitourinary Syndrome of Menopause/Vulvovaginal Atrophy

> **NCT03782480** · PHASE3 · UNKNOWN · sponsor: **Center for Vulvovaginal Disorders** · enrollment: 40 (estimated)

## Conditions studied

- Menopause
- Genitourinary Syndrome of Menopause
- Vulvovaginal Atrophy
- Menopause Syndrome
- Dyspareunia

## Interventions

- **DRUG:** Intrarosa
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT03782480
- **Lead sponsor:** Center for Vulvovaginal Disorders
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-03-02
- **Primary completion:** 2021-01-02
- **Final completion:** 2021-01-02
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2019-01-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03782480

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03782480, "Examining Effects of Intrarosa in Women With Genitourinary Syndrome of Menopause/Vulvovaginal Atrophy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03782480. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*